Geneva Advisors’s Rockwell Medical RMTI Stock Holding History

Geneva Advisors’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$166K	Hold	191	–	–	﹤0.01%	689
2017 Q1	$131K	Buy	191 +7	+4%	+$4.61K	﹤0.01%	703
2016 Q4	$132K	Buy	+184	New	+$127K	﹤0.01%	712

Other funds holding RMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BKS Advisors Southfield, Michigan $249M AUM 14.37% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geneva Advisors's RMTI Position: Q2 2017 in Review

Geneva Advisors held its Rockwell Medical (RMTI) position steady in Q2 2017 at 191 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #689.

Geneva Advisors first reported a position in RMTI in Q4 2016 and has held it in 3 quarters since. 83 funds tracked by Wall St. Rank hold RMTI as of Q2 2017.

Geneva Advisors held 191 shares of Rockwell Medical worth $166K as of Q2 2017.
Geneva Advisors left its Rockwell Medical share count unchanged in Q2 2017.
Rockwell Medical made up ﹤0.01% of Geneva Advisors's portfolio in Q2 2017, its #689 holding.
Geneva Advisors first reported a position in Rockwell Medical in Q4 2016 and has held it in 3 quarters since.
83 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.